Listen "Hartmut Ehrlich: CEO of Abivax"
Episode Synopsis
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.
More episodes of the podcast BioBoss
Todd Harris: CEO of Tyra Biosciences
30/08/2025
Eduardo Bravo: CEO of Citryll
26/07/2025
Abbas Kazimi: CEO of Nimbus Therapeutics
28/06/2025
Derek Adams: CEO of Stellular Bio
24/05/2025
Welcome to Season 7 of BioBoss
05/12/2024